Business Context and Reporting Period
Company: National Research Corporation (NRC Health)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 30, 2000
Business Overview: The Company provides survey research and data processing services. Key operational developments include the rollout of proprietary "QualPro" technology and the renovation of a new headquarters building in Lincoln, Nebraska, with a planned move in September 2000.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2000 |
Six Months Ended June 30, 2000 |
Six Months Ended June 30, 1999 |
|---|---|---|---|
| Revenues | $4,638,336 | $9,093,159 | $7,968,264 |
| Net Income | $650,383 | $1,144,145 | $223,649 |
| Operating Income | $738,406 | $1,311,031 | $86,680 |
| Operating Margin | 15.9% | 14.5% | 1.1% |
| Net Cash from Operations | N/A | $536,478 | $2,638,743 |
| Cash & Equivalents (End of Period) | $3,723,782 | $3,723,782 | $2,511,660 |
| Working Capital | $3,453,278 | $3,453,278 | N/A |
| Debt (Current Portion) | $5,714,748 | $5,714,748 | N/A |
Note: Debt figures include the construction financing line of credit ($5.7M) and current notes payable ($14,748).
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 7.7% for the quarter and 14.1% for the six-month period compared to 1999, driven by expanded scope of work with existing clients and new client acquisitions.
- Profitability Surge: Net income for the six months ended June 30, 2000, rose to $1.14 million from $224,000 in the prior year. Operating margins improved significantly from 1.1% to 14.5% (six-month comparison).
- Expense Efficiency: Direct expenses decreased as a percentage of revenue from 70.0% to 55.3% (six-month comparison) due to technology investments reducing labor, printing, and fieldwork costs.
- Depreciation Increase: Depreciation and amortization expenses increased 75.3% year-over-year (six months) due to additional amortization of software and computer equipment.
- Cash Flow Variance: Net cash provided by operating activities decreased to $536,000 from $2.6 million in the prior year, attributed to the timing of receivable collections and costs incurred in advance of billings.
Guidance, Outlook, and Risks
- Capital Expenditures: The Company plans to spend an additional $700,000 in the remainder of 2000 to renovate its new headquarters. It expects to secure long-term financing of approximately $5.8 million for the building.
- Expense Outlook: Management expects direct expenses as a percentage of revenue to rise slightly for the balance of 2000 but remain lower than 1999 levels.
- Legal Contingency: The Company is involved in litigation with Cap Gemini America, Inc. Cap Gemini sued for approximately $1.1 million regarding a consulting agreement. NRC Health filed a $4 million counter-suit alleging failure to fulfill terms regarding the QualPro software. Management believes the outcome will have little or no impact on operations.
- Accounting Changes: The Company is evaluating the impact of new accounting standards (SFAS 133, SAB No. 101, and FASB Interpretation No. 44) but does not currently expect significant effects on financial reporting.
Investor Verification Checklist
- Debt Structure: Verify the terms of the $5.7 million construction financing line of credit and the status of the anticipated $5.8 million long-term building financing.
- Legal Exposure: Monitor the status of the $4 million counter-suit against Cap Gemini and the potential impact on the QualPro technology rollout.
- Cash Flow Timing: Assess the sustainability of operating cash flows given the significant decrease in 2000 compared to 1999 due to billing timing.
- Revenue Recognition: Review the $3.3 million in deferred revenues and $1.1 million in unbilled revenues to understand future revenue recognition patterns.
- Capital Allocation: Confirm the completion of the headquarters renovation and the move scheduled for September 2000.